|
|
|
|
A more recent version of this article appeared on September 1, 2007
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on January 24, 2007
Revised on May 24, 2007
Accepted on June 15, 2007
Kinases as Inducers of the Phosphoinositide-3 Kinase Signaling Pathway
*Lady Davis Institute, Sir Mortimer B. Davis-Jewish General Hospital, Montréal, QC, Canada H3T 1E2;
Department of Biochemistry and McGill Cancer Center, Montréal, QC, Canada H3G 1Y6
Monitoring Editor: J. Silvio Gutkind
Phosphoinositide-3 kinase (PI3K) plays an important role in signal transduction in response to a wide range of cellular stimuli involved in cellular processes that promote cell proliferation and survival. Phosphorylation of the
subunit of the eukaryotic translation initiation factor eIF2 at Ser51 takes place in response to various types of environmental stress and is essential for regulation of translation initiation. Herein, we show that a conditionally active form of the eIF2
kinase PKR acts upstream of PI3K and turns on the Akt/PKB-FRAP/mTOR pathway leading to S6 and 4E-BP1 phosphorylation. Also, induction of PI3K signaling antagonizes the apoptotic and protein synthesis inhibitory effects of the conditionally active PKR. Furthermore, induction of the PI3K pathway is impaired in PKR-/- or PERK-/- mouse embryonic fibroblasts (MEFs) in response to various stimuli that activate each eIF2
kinase. Mechanistically, PI3K signaling activation is indirect and requires the inhibition of protein synthesis by eIF2
phosphorylation as demonstrated by the inactivation of endogenous eIF2
by siRNA or utilization of MEFs bearing the eIF2
Ser51Ala mutation. Our data reveal a novel property of eIF2
kinases as activators of PI3K signaling and cell survival.
These authors contributed equally to this work.
Address correspondence to:
Antonis E. Koromilas (antonis.koromilas{at}mcgill.ca)
This article has been cited by other articles:
![]() |
F. Fala, W. L. Blalock, P. L. Tazzari, A. Cappellini, F. Chiarini, G. Martinelli, A. Tafuri, J. A. McCubrey, L. Cocco, and A. M. Martelli Proapoptotic Activity and Chemosensitizing Effect of the Novel Akt Inhibitor (2S)-1-(1H-Indol-3-yl)-3-[5-(3-methyl-2H-indazol-5-yl)pyridin-3-yl]oxypropan2-amine (A443654) in T-Cell Acute Lymphoblastic Leukemia Mol. Pharmacol., September 1, 2008; 74(3): 884 - 895. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Raven, D. Baltzis, S. Wang, Z. Mounir, A. I. Papadakis, H. Q. Gao, and A. E. Koromilas PKR and PKR-like Endoplasmic Reticulum Kinase Induce the Proteasome-dependent Degradation of Cyclin D1 via a Mechanism Requiring Eukaryotic Initiation Factor 2{alpha} Phosphorylation J. Biol. Chem., February 8, 2008; 283(6): 3097 - 3108. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Baltzis, O. Pluquet, A. I. Papadakis, S. Kazemi, L.-K. Qu, and A. E. Koromilas The eIF2{alpha} Kinases PERK and PKR Activate Glycogen Synthase Kinase 3 to Promote the Proteasomal Degradation of p53 J. Biol. Chem., October 26, 2007; 282(43): 31675 - 31687. [Abstract] [Full Text] [PDF] |
||||